Raia Drogasil S.A. (OTCMKTS:RADLY) Sees Significant Decline in Short Interest

Raia Drogasil S.A. (OTCMKTS:RADLY) saw a large drop in short interest in July. As of July 31st, there was short interest totaling 25,098 shares, a drop of 93.8% from the July 15th total of 402,126 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 15,813 shares, the short-interest ratio is presently 1.6 days.

Raia Drogasil Stock Down 1.1%

RADLY traded down $0.04 during midday trading on Thursday, hitting $3.46. The stock had a trading volume of 5,899 shares, compared to its average volume of 68,291. Raia Drogasil has a 1 year low of $3.01 and a 1 year high of $5.34. The business has a fifty day moving average of $3.57 and a 200 day moving average of $4.19.

Raia Drogasil (OTCMKTS:RADLY) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.05 EPS for the quarter, hitting the consensus estimate of $0.05. The business had revenue of $2.17 billion for the quarter, compared to analysts’ expectations of $2.32 billion. On average, analysts forecast that Raia Drogasil will post 0.17 earnings per share for the current fiscal year.

About Raia Drogasil

Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.

The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.